Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
VictoryShares Dividend Accelerator ETF | VSDA | Jan 30, 2025 | 52.71 | +0.79 |
VictoryShares US Small Cap Volatility Wtd ETF | CSA | Jan 30, 2025 | 76.86 | +1.04 |
Vident Core U.S. Bond Strategy Fund | VBND | Jan 30, 2025 | 43.18 | +0.07 |
Vident Core U.S. Equity ETF | VUSE | Jan 30, 2025 | 61.48 | +0.85 |
Vident International Equity Fun | VIDI | Jan 30, 2025 | 25.67 | +0.94 |
Viemed Healthcare | VMD | Jan 30, 2025 | 8.31 | +0.36 |
Vigil Neuroscience | VIGL | Jan 30, 2025 | 2.35 | +7.31 |
Viking Holdings | VIK | Jan 30, 2025 | 51.69 | +2.82 |
Viking Therapeutics | VKTX | Jan 30, 2025 | 33.69 | +0.78 |
Village Bank And Trust Financial | VBFC | Jan 30, 2025 | 77.60 | -0.51 |
Village Farms International | VFF | Jan 30, 2025 | 0.70 | -0.79 |
Village Super Market A | VLGEA | Jan 30, 2025 | 34.29 | +0.03 |
Vimeo | VMEO | Jan 30, 2025 | 6.81 | +2.41 |
Vince Holding | VNCE | Jan 30, 2025 | 3.53 | -4.34 |
Vincerx Pharma | VINC | Jan 30, 2025 | 1.50 | -3.85 |
Vinci Partners A | VINP | Jan 30, 2025 | 10.29 | +2.29 |
Vine Hill Capital Investment | VCIC | Jan 30, 2025 | 10.05 | 0.00 |
Vine Hill Capital Investment | VCICU | Jan 30, 2025 | 10.15 | -0.49 |
VinFast Auto | VFS | Jan 30, 2025 | 4.06 | +6.28 |
Viomi Technology ADR | VIOT | Jan 30, 2025 | 1.41 | -4.08 |
Viper Energy Partners | VNOM | Jan 30, 2025 | 46.24 | -1.28 |
Vipshop ADR | VIPS | Jan 30, 2025 | 14.97 | +3.89 |
Vir Biotechnology | VIR | Jan 30, 2025 | 10.31 | -5.41 |
Viracta Therapeutics | VIRX | Jan 30, 2025 | 0.16 | +0.91 |
Virax Biolabs | VRAX | Jan 30, 2025 | 1.69 | -11.98 |
Virco Manufacturing | VIRC | Jan 30, 2025 | 11.02 | +0.64 |
Virgin Galactic | SPCE | Jan 30, 2025 | 4.74 | +5.33 |
Virginia National Bank | VABK | Jan 30, 2025 | 36.46 | +0.28 |
Viridian Therapeutics | VRDN | Jan 30, 2025 | 20.08 | +3.35 |
VirnetX | VHC | Jan 30, 2025 | 8.90 | -2.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.